Evidence map›Paper›PMID 24488707›Full record

ReviewNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2014

Neuroimaging the epileptogenic process.

Sandy R Shultz, Terence J O'Brien, Maria Stefanidou, Ruben I Kuzniecky

Abstract readReview
In one paragraph

Review in Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Neuroglia and brain energy metabolism.Handbook of clinical neurology · 2025
    Review
  5. Article
  6. The metabolic basis of epilepsy.Nature reviews. Neurology · 2022
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Hungry Neurons: Metabolic Insights on Seizure Dynamics.International journal of molecular sciences · 2017
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Neurology--the next 10 years.Nature reviews. Neurology · 2015
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sandy R ShultzDepartment of Medicine, The Melbourne Brain Centre, The Royal Melbourne Hospital, The University of Melbourne, Building 144, Royal Parade, Parkville, VIC, 3010, Australia, sshultz@unimelb.edu.au.
Terence J O'Brien
Maria Stefanidou
Ruben I Kuzniecky

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epilepsy is one of the most common chronic neurological conditions worldwide. Anti-epileptic drugs (AEDs) can suppress seizures, but do not affect the underlying epileptic state, and many epilepsy patients are unable to attain seizure control with AEDs. To cure or prevent epilepsy, disease-modifying interventions that inhibit or reverse the disease process of epileptogenesis must be developed. A major limitation in the development and implementation of such an intervention is the current poor understanding, and the lack of reliable biomarkers, of the epileptogenic process. Neuroimaging represents a non-invasive medical and research tool with the ability to identify early pathophysiological changes involved in epileptogenesis, monitor disease progression, and assess the effectiveness of possible therapies. Here we will provide an overview of studies conducted in animal models and in patients with epilepsy that have utilized various neuroimaging modalities to investigate epileptogenesis.

Indexed as

AnimalsBiomarkersBrainBrain MappingEpilepsyHumansMagnetic Resonance ImagingMagnetic Resonance SpectroscopyPositron-Emission TomographyBiomarkers

Identifiers

PMID24488707
PMCPMC3996128

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.